Different methods in COVID-19 treatments
DOI:
https://doi.org/10.54097/hset.v14i.1592Keywords:
Clinical, Covid-19, Treatment.Abstract
COVID-19 is a global pandemic starting from China in late 2019 and spread over the world dramatically rapid. A lot of methods were tried by experts to find treatments of COVID-19. Compared with COVID-19, not only the death rate but also spread rate is lower, as well as its existing time. It is also possible that transmitted the virus through eyes, noses and ears. Vaccination has been used as precaution treatment. And some small molecules are used to treat patients who have positive results in severe situation. Adults and pediatric patients who infect COVID-19 pandemic in mild to moderate situation, can use small molecule treatments in emergency only. However, vaccination is unable to protect people 100% and small molecules, such as paxlovid, have not been approved, but have been authorized for emergency use by Food and Drug Administration (FDA). This review focused on methods and mechanism of different treatments of COVID-19.
Downloads
References
Huang, C. et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”, Lancet 395, 497-506 (2020)
Da Costa V.G., Moreli M.L., et al, “The Emergence of SARS, MERS and Novel SARS-2 Coronaviruses in the 21st Century”, Arch Virol., 2020,165(7):1517-1526, DOI:10.1007/s00705-020-04628-0
“The SARS-CoV-2 main protease as drug target”, Research School of Chem., Australian National University, 20200629
Coronavirus Disease 2019 (COVID-19)”. U.S. Centres for Disease Control and Prevention (CDC). Retrieved 6 December 2020
Zhou, P. et al. “A pneumonia outbreak associated with a new coronavirus of probable bat origin”, Nature 579, 270-273 (2020)
Robert Bollinger, M.D. et al. “COVID Variants: What You Should Know”, Updated on April 8, 2022 at https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/a-new-strain-of-coronavirus-what-you-should-know
From https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html
Dr. Anthony Melvin Crasto, Ph.D WorldDrugTracker, Glenmark scientist (Ph.D, ICT), “Small Molecules as Antiviral Drugs”, Eurekamoments in Organic Chemistry, accessed on April 2022, from http://amcrasto.theeurekamoments.com/small-molecules-as-antiviral-drugs/
“RNA polymerase”, Wikipedia, accessed on April 2022, from RNA polymerase - Wikipedia
Huang, C. et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”, Lancet 395, 497-506 (2020)
Zhou, P. et al. “A pneumonia outbreak associated with a new coronavirus of probable bat origin”, Nature 579, 270-273 (2020)
Harcourt, B. H. et al. “Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity”, J. Virol. 78, 13600-13612 (2004)
Use of Paxlovid (PF-07321332 and ritonavir) for treating COVID-19, EUROPEAN MEDICINES AGENCY Retrieved 16 December 2021
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
